CTRI/2019/03/018136Completed未知
Predictive Value of Circulating Free DNA to assess Clinical Outcome in Patients with Oral Cancer
RMLIMS0 sites30 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Enrollment
- 30
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
Inclusion Criteria
- •1. Treatment naive cases with early and
- •locally advanced cancer of oral cavity, confirmed by biopsy ( histopathology will be gold standard for diagnosis).
- •2. Potential candidate for surgery
- •3. Performance status: ECOG 0-2
- •4. Patient consent to be part of study.
Exclusion Criteria
- •1. Patients having a history of any other malignancy from which the patient has been disease-free for less than 2 years, with the exception of adequately treated basal or squamous cell carcinoma of skin.
- •2. Metastatic cancer of oral cavity.
- •Performance status: ECOG: >=3.
- •Presence of second malignancy.
- •Patients unwilling to take active treatment or to join the study.
- •A serious co-existing medical condition likely to interfere with lab results including a potentially serious infection.
Investigators
Similar Trials
Completed
Not Applicable
Cell-free DNA as a prognostic biomarker in patients with COVID-19 diseasecfDNA in patients with COVID-19DRKS00031641niversitätsmedizin Mainz72
Recruiting
Not Applicable
Quantification of Circulating tumor DNA to assess treatment response in metastatic prostate cancer patientsmetastatic prostate cancerNL-OMON24467Erasmus Medical Center95
Not yet recruiting
Not Applicable
Quantification of circulating cell-free DNA in the plasma of cancer patients during radiation therapymalignant tumorJPRN-UMIN000003715Yokohama City University, School of Medicine30
Recruiting
Phase 4
The use of donor-derived circulating cell free DNA for early detection of rejection and to modulate immunosuppression following liver transplantation: A randomized controlled trial.CTRI/2023/10/059270Amrita institute of medical sciences and research
Not yet recruiting
Not Applicable
Clinical validation of circulating cell free DNA [ccfDNA] as a biomarker of metabolic healthObesityACTRN12622001326785Commonwealth Scientific and Industrial Research Organisation100